Skip to content

Prospective investigation of efficacy for blood culture of a new antiseptic Olanexidine Gluconate 1.5%.

Prospective investigation of efficacy for blood culture of a new antiseptic Olanexidine Gluconate 1.5%. - Prospective investigation of efficacy for blood culture of a new antiseptic Olanexidine Gluconate 1.5%.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031495
Enrollment
100
Registered
2018-02-28
Start date
2017-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Case of suspected blood stream infection with blood culture.

Interventions

Apply 1.5% Olamexidine gluconate twice, then dry it before applying blood culture. Blood cultures are taken 2 sets and the result is judged as contamination with the result. The skin site exposed to

Sponsors

Koto hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Case in which blood culture was carried out on suspicion of bloodstream infection over 38 degrees or clinically carried out in Kodo hospital during daytime on weekdays. (2)Patients who understand the contents of the examination, and can observe it (3)Agreement from patients or subsutituted person

Exclusion criteria

Exclusion criteria: (1)Patients already receiving antibiotic treatment (2)Patients who had an allergy to a study drug or gluconic acid chlorhexidine (3)Patients who judged inappropriate cases

Design outcomes

Primary

MeasureTime frame
Primary outcome is the ratio of contamination.

Secondary

MeasureTime frame
Secondary outcome is determined to assess the rate of any adverse effect such as vital sign, subjective and objective symptom, erythema or irritation of the skin.

Countries

Japan

Contacts

Public ContactTakahiro Yamamoto

Koto hospital Division of emergency

gakkai@gogomotty.com03-3685-2166

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026